Avid Bioservices (CDMO) Earnings Date, Estimates & Call Transcripts → Revealed: The Unknown Biotech Powering AI in Healthcare (From Behind the Markets) (Ad) Free CDMO Stock Alerts $8.62 -0.12 (-1.37%) (As of 05/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJun. 19EstimatedActual EPS (Apr. 24) -$0.08 Missed By -$0.06 Consensus EPS (Apr. 24) -$0.02 Get Avid Bioservices Earnings AlertsEnter your email address below to receive the latest news and earnings results for CDMO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCDMO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CDMO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsBanking Apocalypse Ahead: Secure Your Savings Today!During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. We warned about 484 — an accuracy rate of 99.8% Now, I have a new warning.See what it is here! Avid Bioservices Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.04)($0.04)($0.04) Q2 20241($0.07)($0.07)($0.07) Q3 20241$0.01$0.01$0.01 Q4 20241$0.03$0.03$0.03 FY 20244($0.07)($0.07) ($0.07)CDMO Earnings Date and InformationAvid Bioservices last announced its quarterly earnings results on April 24th, 2024. The biopharmaceutical company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.06. The business earned $33.82 million during the quarter, compared to analysts' expectations of $33.80 million. Avid Bioservices has generated ($0.27) earnings per share over the last year (($0.27) diluted earnings per share). Avid Bioservices has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 19th, 2024 based off prior year's report dates.Read More Avid Bioservices Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/19/2024(Estimated)------- 4/24/2024Q3 2024($0.02)($0.08)($0.06)($0.07)$33.80 million$33.82 million12/7/2023Q2 2024($0.12)($0.15)($0.03)($0.15)$33.55 million$25.40 million9/7/2023Q1 2024($0.04)($0.03)+$0.01($0.03)$34.00 million$37.73 million 6/21/2023Q2 2023($0.02)$0.05+$0.07-$39.00 million$39.80 million 3/13/2023Q3 2023($0.08)$0.03+$0.11$0.05$36.00 million$38.02 million12/6/2022Q2 2023($0.05)($0.04)+$0.01($0.06)$31.00 million$34.76 million Get the Latest News and Ratings for CDMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. 9/6/2022Q1 2023$0.03$0.02($0.01)$0.02$34.00 million$36.69 million6/29/2022Q4 2022($0.02)$0.04+$0.06($1.57)$29.20 million$31.23 million3/8/2022Q3 2022$0.05$0.06+$0.01$0.08$28.00 million$31.51 million 12/7/2021Q4 2021$0.02$0.06+$0.04$0.08$25.00 million$26.11 million 9/7/2021Q3 2021$0.04$0.10+$0.06$0.10$25.00 million$30.75 million 6/28/2021Q2 2021$0.01($0.04)($0.05)($0.04)$20.70 million$27.61 million 3/7/2021Q1 2021($0.03)$0.01+$0.04$0.01$20.00 million$21.81 million 12/1/2020Q4 2020($0.06)$0.01+$0.07$0.01$14.00 million$21.06 million 9/1/2020Q3 2020($0.06)$0.06+$0.12$0.06-$25.39 million 6/30/2020Q2 2020($0.16)($0.11)+$0.05($0.11)$9.55 million$12.55 million 3/10/2020Q1 2020($0.03)($0.06)($0.03)($0.06)$16.80 million$13.59 million 12/9/2019Q2($0.04)($0.03)+$0.01($0.03)$14.34 million$18.31 million 9/5/2019Q1($0.03)($0.08)($0.05)($0.08)$14.37 million$15.25 million 6/27/2019Q4($0.03)($0.02)+$0.01($0.02)$15.53 million$17.06 million Avid Bioservices Earnings - Frequently Asked Questions When is Avid Bioservices's earnings date? Avid Bioservices has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 19th, 2024 based off last year's report dates. Learn more on CDMO's earnings history. Did Avid Bioservices beat their earnings estimates last quarter? In the previous quarter, Avid Bioservices (NASDAQ:CDMO) missed the analysts' consensus estimate of ($0.02) by $0.06 with a reported earnings per share (EPS) of ($0.08). Learn more on analysts' earnings estimate vs. CDMO's actual earnings. How much revenue does Avid Bioservices generate each year? Avid Bioservices (NASDAQ:CDMO) has a recorded annual revenue of $136.74 million. How much profit does Avid Bioservices generate each year? Avid Bioservices (NASDAQ:CDMO) has a recorded net income of $260,000.00. CDMO has generated -$0.27 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: AVTE Earnings HROW Earnings SVRA Earnings ORIC Earnings YMAB Earnings ABUS Earnings PHAR Earnings ALT Earnings CMPS Earnings SIGA Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: TD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's Earnings This page (NASDAQ:CDMO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
